Event Type
Disclosure
Mandatory
Variant
8-K
. Item 5.07. Submission of Matters to a Vote of Security Holders. The Company held its Annual Meeting on May 29, 2025. As of the close of business on April 1, 2
below, at the Annual Meeting, the Company’s stockholders approved an amendment (“Plan Amendment”) to the Esperion Therapeutics, Inc. 2022 Stock Option and Incen
. Financial Statements and Exhibits. d) Exhibits. Exhibit No. Description 10.1 Esperion Therapeutics, Inc. 2022 Stock Option and Incentive Plan and its Amendmen